Download FREE Report Sample
Download Free sampleFollicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Follicle Stimulating Hormone Market contains market size and forecasts of Follicle Stimulating Hormone in global, including the following market information:
Global Follicle Stimulating Hormone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Follicle Stimulating Hormone Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Follicle Stimulating Hormone companies in 2021 (%)
The global Follicle Stimulating Hormone market was valued at 1312 million in 2021 and is projected to reach US$ 1578.8 million by 2028, at a CAGR of 2.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Recombinant FSH Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Follicle Stimulating Hormone include Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter and Teva. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Follicle Stimulating Hormone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Follicle Stimulating Hormone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Follicle Stimulating Hormone Market Segment Percentages, by Type, 2021 (%)
Recombinant FSH
Urinary FSH
Global Follicle Stimulating Hormone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Follicle Stimulating Hormone Market Segment Percentages, by Application, 2021 (%)
Infertility Treatment
Assisted Reproductive Technology
Global Follicle Stimulating Hormone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Follicle Stimulating Hormone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Follicle Stimulating Hormone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Follicle Stimulating Hormone revenues share in global market, 2021 (%)
Key companies Follicle Stimulating Hormone sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Follicle Stimulating Hormone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
